← Leaderboards
Alexei Kisselev
Dartmouth College
$3,573,035
Attributed
$3,721,212
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $677.8K · FY2007–21$1M$750K$500K$250K$0
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
Funding mix
By agency
NIH$3,721,212 · 3
By mechanism
R01$3,424,858 · 2
R41$296,354 · 1
Top collaborators
- Alexandre Pletnev1 shared
Most similar at Dartmouth College
Same institution · by research overlap
- Ruth W. Craig$3,677,074
- Amy E Keating$19,695,788
- Michael B Sporn$8,497,060
Others in their field
Top investigators on “Site”
- Lawrence Corey · Fred Hutchinson Cancer Center$727,416,881
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Jeffrey P Krischer · University Of South Florida$630,131,001
- David Divins · Consortium For Ocean Leadership, Inc$609,772,544
- Bambra Strokes · Ppd Development Lp$526,656,217
- Tracy L Nolen · Research Triangle Institute$474,487,152
Research focus
SiteMulticatalytic Endopeptidase ComplexInhibitor/AntagonistResistanceProteasome InhibitorMultiple MyelomaCellsBortezomibMalignant NeoplasmsProteinsClinical TrialsApoptoticPlayToxic EffectNon-MalignantApoptosisBreast Cancer ModelBreast Cancer CellActive SitesMalignant Breast NeoplasmPropertyStructureCell LineCancer Cell
Grant awards (12)
Proteasome inhibitors for the treatment of solid tumors$356,476
R01 · FY2021 · CA · contact PI
Proteasome inhibitors for the treatment of solid tumors$356,318
R01 · FY2020 · CA · contact PI
Proteasome inhibitors for the treatment of solid tumors$345,478
R01 · FY2019 · CA · contact PI
Proteasome inhibitors for the treatment of solid tumors$356,014
R01 · FY2018 · CA · contact PI
Proteasome inhibitors for the treatment of solid tumors$381,450
R01 · FY2017 · CA · contact PI
Novel Inhibitors of PSMB7 and PSMB10 for the Treatment of Multiple Myeloma$296,354
R41 · FY2017 · CA · contact PI
Different active sites of the proteasome as drug targets in cancer$265,226
R01 · FY2011 · CA · contact PI
Different active sites of the proteasome as drug targets in cancer$273,429
R01 · FY2010 · CA · contact PI
Different active sites of the proteasome as drug targets in cancer$273,429
R01 · FY2009 · CA · contact PI
Different active sites of the proteasome as drug targets in cancer$270,180
R01 · FY2009 · CA · contact PI
Different active sites of the proteasome as drug targets in cancer$273,429
R01 · FY2008 · CA · contact PI
Different active sites of the proteasome as drug targets in cancer$273,429
R01 · FY2007 · CA · contact PI